Indications |
Oral Alzheimer's dementia Adult: Initially, 4 mg bid for 4 wk increased to 8 mg bid for at least 4 wk. May further increase to 12 mg bid based on response and tolerance. Renal impairment: Moderate: Max: 16 mg daily.
Special Populations: Moderate hepatic or renal impairment: Reduce dose. Max Dose: 16 mg/day. |
||||
Contraindications |
Hypersensitivity; severe liver or kidney dysfunction; lactation; disorders of galactose metabolism; urinary retention or GI obstruction. Lactation. | ||||
Warnings / Precautions |
Mild-moderate hepatic impairment; supraventricular conduction abnormalities; asthma; COPD; pregnancy; peptic ulcers. May increase gastric acid production. | ||||
Adverse Reactions |
GI disturbances; bradycardia, CNS disturbances; tremor, anorexia, wt loss; urinary tract infection; anaemia; rhinitis. Potentially Fatal: CV effects; convulsion; delirium; rectal haemorrhage; thrombocytopenia. |
||||
Drug Interactions |
Increased serum concentrations when used with drugs that inhibit CYP2D6 (e.g. quinidine, fluoxetine, fluvoxamine, and paroxetine) and CYP3A4 (e.g. ketoconazole and ritonavir). Cimetidine may increase the bioavailability of galantamine. Increased risk of gastric ulcer when used with NSAIDs. Potentially Fatal: Amiodarone, β-blockers, diltiazem or verapamil; NSAIDs; digoxin. See Below for More galantamine Drug Interactions |
||||
Lab Interactions |
Alkaline phosphatase level may increase. | ||||
Food Interactions |
Avoid alcohol and St John's wort. | ||||
Mechanism of Actions |
Galantamine is a centrally-acting cholinesterase inhibitor, elevating acetylcholine in the cerebral cortex. Glutamine and serotonin levels may also be increase. It has nicotinic receptor agonist properties. Duration: 3 hr. Absorption: Well absorbed from the GI tract. Distribution: Protein binding: About 18%. Metabolism: Partly metabolised by CYP2D6 and CYP3A4. Excretion: Elimination half-life: About 7-8 hr. |
||||
Administration |
Should be taken with food. |
||||
Storage Conditions |
Oral: Store at 25°C. | ||||
ATC Classification |
N06DA04 - galantamine ; Belongs to the class of anticholinesterases. Used in the management of dementia. | ||||
Storage |
Oral: Store at 25°C. | ||||
Available As |
|
Galantamine
Post Review about Galantamine Click here to cancel reply.
Galantamine Containing Brands
Galantamine is used in following diseases
Drug - Drug Interactions of Galantamine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.